Mayes Rebecca A, Siegrist Emily A, Mathew Julia, Neely Stephen B, McCloskey Cindy B, White Bryan P
University of Oklahoma Medical Center at OU Health, Department of Pharmacy, Oklahoma City, OK, USA.
The University of Oklahoma College of Pharmacy, Pharmacy office of the Dean, Oklahoma City, OK, USA.
JAC Antimicrob Resist. 2024 Sep 10;6(5):dlae144. doi: 10.1093/jacamr/dlae144. eCollection 2024 Oct.
To evaluate the utility of follow-up blood cultures (FUBCs) for Gram-negative bloodstream infection (BSI) in ICU patients and identify risk factors for repeat positive cultures.
This was a single-centre, retrospective cohort study of critically ill adults with Gram-negative BSI between 1 January 2015 and 1 January 2020. Critically ill patients with one or more blood cultures positive for a Gram-negative organism were included. Descriptive and inferential statistics were performed with an alpha of 0.05.
A total of 148 critically ill patients with Gram-negative BSI were included, with 42 patients (28.4%) having one or more positive FUBCs. The majority (66.2%) were admitted to a medical ICU. The most common organisms isolated were ( = 56, 37.8%) and ( = 26, 17.6%). Significant patient risk factors associated with a positive FUBC on univariate regression included: MDR organisms, immunocompromised status, fever, vasopressor use at time of FUBC, lack of source control attainment, and higher quick Pitt bacteraemia score. Multivariable penalized logistic regression indicated that lack of source control containment and less time from index to FUBC remained significantly associated with repeat positive FUBC.
This is the first study to investigate the use of FUBC for Gram-negative BSI in exclusively ICU patients. Risk factors for repeat positive FUBC in this population include lack of source control and less time between index and FUBC. Prospective studies are needed to fully elucidate the role of FUBCs in critically ill patients with Gram-negative BSI.
评估重症监护病房(ICU)患者革兰阴性菌血流感染(BSI)的随访血培养(FUBC)的效用,并确定培养结果再次呈阳性的危险因素。
这是一项单中心回顾性队列研究,研究对象为2015年1月1日至2020年1月1日期间患有革兰阴性菌BSI的成年危重症患者。纳入了血培养中一种或多种革兰阴性菌呈阳性的危重症患者。采用α=0.05进行描述性和推断性统计分析。
共纳入148例患有革兰阴性菌BSI的危重症患者,其中42例(28.4%)的FUBC结果为一次或多次阳性。大多数患者(66.2%)入住内科ICU。分离出的最常见病原体为[具体病原体1](n=56,37.8%)和[具体病原体2](n=26,17.6%)。单因素回归分析显示,与FUBC结果呈阳性相关的显著患者危险因素包括:多重耐药菌、免疫功能低下状态、发热、进行FUBC时使用血管活性药物、未实现感染源控制以及较高的快速皮特菌血症评分。多变量惩罚逻辑回归分析表明,未实现感染源控制以及从初次血培养到FUBC的时间较短仍然与FUBC结果再次呈阳性显著相关。
这是第一项专门针对ICU患者革兰阴性菌BSI进行FUBC研究的报告。该人群中FUBC结果再次呈阳性的危险因素包括未实现感染源控制以及初次血培养和FUBC之间的时间较短。需要开展前瞻性研究以全面阐明FUBC在革兰阴性菌BSI危重症患者中的作用。